Company Sunny Pharma Co S.r.l. with Fiscal Code 25581146
recorded a turnover of 2024 of
229.538,
with a net profit of
-53.623
and having an average number of employees of
4.
The company operates in the field of Comerţ cu amănuntul al produselor farmaceutice having the NACE code 4773.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
Sunny Pharma Co S.r.l.
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
288.971
240.985
202.666
203.094
241.236
275.217
260.991
233.101
194.412
229.538
Total Income - EUR
292.758
242.447
210.109
219.649
256.308
275.225
261.007
233.108
194.415
229.542
Total Expenses - EUR
288.673
246.632
233.717
216.571
256.009
265.106
233.821
216.966
213.128
283.165
Gross Profit/Loss - EUR
4.085
-4.185
-23.609
3.078
299
10.120
27.186
16.142
-18.713
-53.623
Net Profit/Loss - EUR
3.337
-4.185
-26.884
882
-2.262
7.570
24.628
14.160
-20.366
-53.623
Employees
4
5
4
4
4
3
3
3
4
4
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
In the last year of activity, the sales increased by 18.7%, from 194.412 euro in the year 2023, to 229.538 euro in 2024.
Check the financial reports for the company - Sunny Pharma Co S.r.l.
Financial Rating - SUNNY PHARMA CO S.R.L.
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Financial Rating
Payment Limits - Sunny Pharma Co S.r.l.
See the company's payment capacity for situations in which you conclude contracts with payment terms.
Check Payment Limits
Prob. of insolvency - Sunny Pharma Co S.r.l.
It determines the risk of insolvency based on the submitted accounting balance.
Insolvency Probability
Financial Reports - Sunny Pharma Co S.r.l.
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
Debts, Equity, Inventories, Receivables, Accounts, Assets -
Sunny Pharma Co S.r.l. - CUI 25581146
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Fixed Assets
22.020
14.234
6.827
2.566
130
35
18
9
0
0
Current Assets
66.703
54.302
113.912
87.119
53.338
91.171
87.033
68.800
95.649
87.726
Inventories
29.859
26.302
40.968
22.254
10.883
28.686
27.334
14.388
24.054
20.039
Receivables
34.520
17.549
48.157
56.686
41.114
58.815
55.820
47.785
62.564
64.525
Cash
2.323
10.451
24.786
8.178
1.340
3.669
3.878
6.627
9.031
3.161
Shareholders Funds
16.961
12.603
-18.480
-17.259
-19.187
-11.253
13.624
27.827
5.355
-48.298
Social Capital
4.544
4.498
4.422
4.341
4.257
4.176
4.083
4.096
4.084
4.061
Debts
121.063
104.731
187.191
154.036
118.834
147.784
117.726
85.419
134.596
180.206
Income in Advance
0
0
0
0
0
0
0
0
0
0
Exchange rate - RON
4.9743
4.9465
4.9315
4.9468
4.8371
4.7454
4.6535
4.5681
4.4908
4.445
Main CAEN
"4773 - 4773"
CAEN Financial Year
4773
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
87.726 euro in 2024 which includes Inventories of
20.039 euro, Receivables of
64.525 euro and cash availability of
3.161 euro.
The company's Equity was valued at
-48.298 euro, while total Liabilities amounted to
180.206 euro.
Equity decreased by -53.623 euro, from 5.355 euro in 2023, to -48.298 in 2024.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Sunny Pharma Co S.r.l.